TTPY Insider Trading Activity and SEC Form 4 Filings
TTPY insider trading summary
No open-market insider purchases or sales of TomoTherapy Inc (TTPY) have been reported on SEC Form 4 in the past 12 months.
Latest TTPY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2007 | Michael J Cudahy | Director | Sell | $28.4M (1,278,413 @ $22.25) |
| Oct 16, 2007 | Venture Investors LLC | 10% Owner | Sell | $18.7M (840,908 @ $22.25) |
| Oct 16, 2007 | John Neis | Director | Sell | $18.7M (840,908 @ $22.25) |
| Oct 16, 2007 | Venture Investors LLC | 10% Owner | Sell | $9.5M (426,700 @ $22.25) |
| Oct 16, 2007 | Venture Investors LLC | 10% Owner | Sell | $11.0M (495,996 @ $22.25) |
| Oct 16, 2007 | Stephen C Hathaway | CFO and Treasurer | Sell | $454K (20,400 @ $22.25) |
| Oct 16, 2007 | John Neis | Director | Sell | $9.5M (426,700 @ $22.25) |
| Oct 16, 2007 | Stephen C Hathaway | CFO and Treasurer | Sell | $430K (19,333 @ $22.25) |
| Oct 16, 2007 | John Neis | Director | Sell | $11.0M (495,996 @ $22.25) |
| Oct 16, 2007 | John H Hughes | VP of Business Development | Sell | $2.0M (89,970 @ $22.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.